Chol-CTPP is a ligand with dual targeting effect on blood-brain barrier (BBB) and glioma cells. Lip-CTPP can be gained by Chol-CTPP and another mitochondria targeting ligand (Chol-TPP). Lip-CTPP is a promising potential carrier to exert the anti-glioma effect of doxorubicin (DOX) and lonidamine (LND) collaboratively. Lip-CTPP elevates the inhibition rate of tumor cell proliferation, migration and invasion, promote apoptosis and necrosis, and interfere with mitochondrial function[1].
Molecular Weight:
2884.62
Formula:
C144H263N3O53
Target:
Apoptosis,Reactive Oxygen Species (ROS)
Application Notes:
Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted
